Charles F. Carey, M.D.

NPI 1104822014ActiveIndividual· Internal Medicine, Cardiovascular Disease· Saint Louis, MO

Internal Medicine, Cardiovascular Disease (M.D.) in Saint Louis, Missouri, trained at University of Missouri, Kansas City, School of Medicine (class of 1991). Their prescriptions cost Medicare Part D more than their services did: $3,039,954 for 12,921 claims, against $167,619 paid for services in 2024. Abbott Laboratories was the largest of 11 companies reporting payments in 2025, $1,050 in all, mostly food and beverage.

Overview

NPI	1104822014
Status	Active
Entity type	Individual
Credential	M.D.
Sole proprietor	No
NPI issued	Jun 24, 2005
Last updated in NPPES	Aug 3, 2020
Certified by provider	Aug 3, 2020

Specialties and licenses

Taxonomy	Code	License	State
Internal Medicine, Cardiovascular Disease Primary	207RC0000X	105346	MO

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Nov 10, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026	No match	—
New York OMIG · Nov 11, 2026	No match	—
Ohio Medicaid · Nov 11, 2026	No match	—
Pennsylvania Medicheck · Nov 11, 2026	No match	—
Washington HCA · Nov 11, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Cardiovascular Disease (Cardiology) (MO)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	1,642
Services billed	3,473 across 56 procedure codes
Paid by Medicare	$167,619

Part D prescriptions in 2024

Prescriptions (claims)	12,921 · 33,078 30-day fills
Patients	1,313
Total drug cost	$3,039,954
Generic share	80% of claims

Medicare sources and data years

Education and affiliations

Medical school	University of Missouri, Kansas City, School of Medicine
Graduation year	1991
Medicare specialty	Cardiovascular Disease (Cardiology)
Telehealth	Offers telehealth